| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.06 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.088 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |